Abstract
Bacteremia poses great risk for morbidity and mortality for immunocompromised cancer patients. Although the presence of bacteria within solid tumors is gaining greater attention, few studies have analyzed species of bacteria in the blood and their effect on cancer clinical outcomes. Using the Kraken 2 taxonomic profiling tool, we classified bacteria present in blood and primary tumors of cervical cancer and melanoma cases. The Cancer Genome Atlas (TCGA) melanoma blood exome files with Pseudomonas species were found to represent a worse disease-free survival (DFS) probability, while a worse overall survival (OS) result was evidenced for both the TCGA and Moffitt Cancer Center melanoma datasets. Cervical cancer cases with reads representing the Bradyrhizobium genus and Bradyrhizobium sp. BTAi1 found in blood and tumor exome files were found to have lower DFS. Additionally, reduced DFS and OS were observed for cervical cancer cases positive for Bacteroides species including Bacteroides fragilis. This study provides novel evidence and a novel approach for indicating that bacteria in blood is associated with cancer recurrence. These findings may guide the development of more efficient prognostic and screening tools related to bacterial blood infections of melanoma and cervical cancer patients.
Similar content being viewed by others
Data availability
Data generated in this study are available in the supporting online material. Any additional information related to these data can be had by emailing the corresponding author.
Abbreviations
- BAM:
-
Binary alignment map
- CESC:
-
Cervical squamous cell cancer
- dbGaP:
-
Database of genotypes and phenotypes
- DFS:
-
Disease-free survival
- GDC:
-
Genomic data commons
- KM:
-
Kaplan–Meier
- NCBI:
-
National Center for Biotechnology Information
- OS:
-
Overall survival
- SKCM:
-
Skin cutaneous melanoma
- TCGA:
-
The cancer genome atlas
- WXS:
-
Whole exome sequence
References
Danai, P. A., Moss, M., Mannino, D. M., & Martin, G. S. (2006). The epidemiology of sepsis in patients with malignancy. Chest, 129(6), 1432–1440. https://doi.org/10.1378/chest.129.6.1432
Chrischilles, E. A., Link, B. K., Scott, S. D., Delgado, D. J., & Fridman, M. (2003). Factors associated with early termination of CHOP therapy and the impact on survival among patients with chemosensitive intermediate-grade non-Hodgkin’s lymphoma. Cancer Control, 10(5), 396–403. https://doi.org/10.1177/107327480301000507
Cosgrove, S. E., Qi, Y., Kaye, K. S., Harbarth, S., Karchmer, A. W., & Carmeli, Y. (2005). The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: Mortality, length of stay, and hospital charges. Infection Control and Hospital Epidemiology, 26(2), 166–174. https://doi.org/10.1086/502522
Rolston, K. V. (2017). Infections in cancer patients with solid tumors: A review. Infectious Disease and Therapy, 6(1), 69–83. https://doi.org/10.1007/s40121-017-0146-1
Orien, S. N., Blijlevens, N. M., Mahfouz, T. H., & Anaissie, E. J. (2003). Infections in patients with hematological cancer: Recent developments. Hematology American Soc Hematol Educ Program., 2003, 438–72. https://doi.org/10.1182/asheducation-2003.1.438
Bochud, P. Y., Eggiman, P., Calandra, T., Van Melle, G., Saghafi, L., & Francioli, P. (1994). Bacteremia due to viridans streptococcus in neutropenic patients with cancer: Clinical spectrum and risk factors. Clinical Infectious Diseases, 18(1), 25–31. https://doi.org/10.1093/clinids/18.1.25
Mikulska, M., Del Bono, V., Bruzzi, P., Raiola, A. M., Gualandi, F., Van Lint, M. T., Bacigalupo, A., & Viscoli, C. (2012). Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients. Infection, 40(3), 271–278.
Baier, C., Linke, L., Eder, M., Schwab, F., Chaberny, I. F., Vonberg, R. P., & Ebadi, E. (2020). Incidence, risk factors and healthcare costs of central line-associated nosocomial bloodstream infections in hematologic and oncologic patients. PLoS ONE, 15(1), e0227772.
Montassier, E., Batard, E., Gastinne, T., Potel, G., & de La Cochetiere, M. F. (2013). Recent changes in bacteremia in patients with cancer: A systematic review of epidemiology and antibiotic resistance. European Journal of Clinical Microbiology and Infectious Diseases, 32(7), 841–850.
Lubwama, M., Phipps, W., Najjuka, C. F., Kajumbula, H., Ddungu, H., Kambugu, J. B., & Bwanga, F. (2019). Bacteremia in febrile cancer patients in Uganda. BMC Research Notes, 12(1), 464.
Gudiol, C., Bodro, M., Simonetti, A., Tubau, F., Gonzalez-Barca, E., Cisnal, M., Domingo-Domenech, E., Jimenez, L., & Carratala, J. (2013). Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clinical Microbiology & Infection, 19(5), 474–479.
Anatoliotaki, M., Valatas, V., Mantadakis, E., Apostolakou, H., Mavroudis, D., Georgoulias, V., Rolston, K. V., Kontoyiannis, D. P., Galanakis, E., & Samonis, G. (2004). Bloodstream infections in patients with solid tumors: Associated factors, microbial spectrum and outcome. Infection, 32(2), 65–71. https://doi.org/10.1007/s15010-004-3049-5
Marin, M., Gudiol, C., Garcia-Vidal, C., Ardanuy, C., & Carratala, J. (2014). Bloodstream infections in patients with solid tumors: Epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center. Medicine (Baltimore), 93(3), 143–149. https://doi.org/10.1097/MD.000000000000002
Kang, C. I., Song, J. H., Chung, D. R., Peck, K. R., Yeom, J. S., Son, J. S., & Wi, Y. M. (2012). Bloodstream infections in adult patients with cancer: clinical features and pathogenic significance of Staphylococcus aureus bacteremia. Support Care Cancer, 20(10), 2371–8.
Taplitz, R. A., Kennedy, E. B., Bow, E. J., Crews, J., Gleason, C., Hawley, D. K., Langston, A. A., Nastoupil, L. J., Rajotte, M., Rolston, K. V., Strasfeld, L., & Flowers, C. R. (2018). Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 36(30), 3043–3054.
Nannan Panday, R. S., Wang, S., van de Ven, P. M., Hekker, T. A. M., Alam, N., & Nanayakkara, P. W. B. (2019). Evaluation of blood culture epidemiology and efficiency in a large European teaching hospital. PLoS ONE, 14(3), e0214052.
Weinstein, M. P. (2003). Blood culture contamination: Persisting problems and partial progress. Journal of Clinical Microbiology, 41(6), 2275–2278. https://doi.org/10.1128/JCM.41.6.2275-2278.2003
Bacconi, A., Richmond, G. S., Baroldi, M. A., Laffler, T. G., Blyn, L. B., Carolan, H. E., Frinder, M. R., Toleno, D. M., Metzgar, D., Gutierrez, J. R., Massire, C., Rounds, M., Kennel, N. J., Rothman, R. E., Peterson, S., Carroll, K. C., Wakefield, T., Ecker, D. J., & Sampath, R. (2014). Improved sensitivity for molecular detection of bacterial and Candida infections in blood. Journal of Clinical Microbiology, 52(9), 3164–3174.
Marlowe, E. M., Hogan, J. J., Hindler, J. F., Andruszkiewicz, I., Gordon, P., & Bruckner, D. A. (2003). Application of an rRNA probe matrix for rapid identification of bacteria and fungi from routine blood cultures. Journal of Clinical Microbiology, 41(11), 5127–5133. https://doi.org/10.1128/JCM.41.11.5127-5133.2003
Grumaz, S., Stevens, P., Grumaz, C., Decker, S. O., Weigand, M. A., Hofer, S., Brenner, T., von Haeseler, A., & Sohn, K. (2016). Next-generation sequencing diagnostics of bacteremia in septic patients. Genome Medicine, 8(1), 73.
Cancer Genome Atlas N. (2015). Genomic classification of cutaneous melanoma. Cell, 161(7), 1681–96.
Cancer Genome Atlas Research N, Albert Einstein College of M, Analytical Biological S, Barretos Cancer H, Baylor College of M, Beckman Research Institute of City of H, Buck Institute for Research on A, Canada's Michael Smith Genome Sciences C, Harvard Medical S, Helen FGCC, Research Institute at Christiana Care Health S, HudsonAlpha Institute for B, Ilsbio LLC, Indiana University School of M, Institute of Human V, Institute for Systems B, International Genomics C, Leidos B, Massachusetts General H, McDonnell Genome Institute at Washington U, Medical College of W, Medical University of South C, Memorial Sloan Kettering Cancer C, Montefiore Medical C, NantOmics, National Cancer I, National Hospital AN, National Human Genome Research I, National Institute of Environmental Health S, National Institute on D, Other Communication D, Ontario Tumour Bank LHSC, Ontario Tumour Bank OIfCR, Ontario Tumour Bank TOH, Oregon H, Science U, Samuel Oschin Comprehensive Cancer Institute C-SMC, International SRA, St Joseph's Candler Health S, Eli, Edythe LBIoMIoT, Harvard U, Research Institute at Nationwide Children's H, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins U, University of B, University of Texas MDACC, University of Abuja Teaching H, University of Alabama at B, University of California I, University of California Santa C, University of Kansas Medical C, University of L, University of New Mexico Health Sciences C, University of North Carolina at Chapel H, University of Oklahoma Health Sciences C, University of P, University of Sao Paulo RaPMS, University of Southern C, University of W, University of Wisconsin School of M, Public H, Van Andel Research I, Washington University in St L. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543(7645):378–84
Wood, D. E., Lu, J., & Langmead, B. (2019). Improved metagenomic analysis with Kraken 2. Genome Biology, 20(1), 257.
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., & Durbin, R. (2009). Genome project data processing S. The sequence alignment/map format and SAMtools. Bioinformatics, 25(16), 2078–9.
Breitwieser, F. P., & Salzberg, S. L. (2020). Pavian: Interactive analysis of metagenomics data for microbiome studies and pathogen identification. Bioinformatics, 36(4), 1303–1304. https://doi.org/10.1093/bioinformatics/btz715
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., Cerami, E., Sander, C., & Schultz, N. (2013). Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 6(269), pl1. https://doi.org/10.1126/scisignal.2004088
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., Antipin, Y., Reva, B., Goldberg, A. P., Sander, C., & Schultz, N. (2012). The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2(5), 401–404. https://doi.org/10.1158/2159-8290.CD-12-0095
Ustun, C., Young, J. H., Papanicolaou, G. A., Kim, S., Ahn, K. W., Chen, M., Abdel-Azim, H., Aljurf, M., Beitinjaneh, A., Brown, V., Cerny, J., Chhabra, S., Kharfan-Dabaja, M. A., Dahi, P. B., Daly, A., Dandoy, C. E., Dvorak, C. C., Freytes, C. O., Hashmi, S., … Riches, M. (2019). Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation, 54(8), 1254–1265.
Peters, B. A., Hayes, R. B., Goparaju, C., Reid, C., Pass, H. I., & Ahn, J. (2019). The microbiome in lung cancer tissue and recurrence-free survival. Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology., 28(4), 731–740.
Patnaik, S. K., Cortes, E. G., Kannisto, E. D., Punnanitinont, A., Dhillon, S. S., Liu, S., & Yendamuri, S. (2021). Lower airway bacterial microbiome may influence recurrence after resection of early-stage non-small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery, 161(2), 419–429.
Qiao, H., Tan, X. R., Li, H., Li, J. Y., Chen, X. Z., Li, Y. Q., Li, W. F., Tang, L. L., Zhou, G. Q., Zhang, Y., Liang, Y. L., He, Q. M., Zhao, Y., Huang, S. Y., Gong, S., Li, Q., Ye, M. L., Chen, K. L., Sun, Y., … Liu, N. (2022). Association of intratumoral microbiota with prognosis in patients with nasopharyngeal carcinoma from 2 hospitals in China. JAMA Oncology, 8(9), 1301–1309. https://doi.org/10.1001/jamaoncol.2022.2810
Louis, P., Hold, G. L., & Flint, H. J. (2014). The gut microbiota, bacterial metabolites and colorectal cancer. Nature Reviews Microbiology, 12(10), 661–72. https://doi.org/10.1038/nrmicro3344
Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N., & Schlemper, R. J. (2001). Helicobacter pylori infection and the development of gastric cancer. The New England Journal of Medicine, 345(11), 784–789. https://doi.org/10.1056/NEJMoa001999
Feng, S. H., Tsai, S., Rodriguez, J., & Lo, S. C. (1999). Mycoplasmal infections prevent apoptosis and induce malignant transformation of interleukin-3-dependent 32D hematopoietic cells. Molecular and Cellular Biology, 19(12), 7995–8002. https://doi.org/10.1128/MCB.19.12.7995
Riquelme, E., Zhang, Y., Zhang, L., Montiel, M., Zoltan, M., Dong, W., Quesada, P., Sahin, I., Chandra, V., San Lucas, A., Scheet, P., Xu, H., Hanash, S. M., Feng, L., Burks, J. K., Do, K. A., Peterson, C. B., Nejman, D., Tzeng, C. D., … McAllister, F. (2019). Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell, 178(4), 795–806. https://doi.org/10.1016/j.cell.2019.07.008
Guo, W., Zhang, Y., Guo, S., Mei, Z., Liao, H., Dong, H., Wu, K., Ye, H., Zhang, Y., Zhu, Y., Lang, J., Hu, L., Jin, G., & Kong, X. (2021). Tumor microbiome contributes to an aggressive phenotype in the basal-like subtype of pancreatic cancer. Communications in Biology, 4(1), 1019.
Ahmed, N., Ali, Z., Riaz, M., Zeshan, B., Wattoo, J. I., & Aslam, M. N. (2020). Evaluation of antibiotic resistance and virulence genes among clinical isolates of Pseudomonas aeruginosa from cancer patients. Asian Pacific Journal of Cancer Prevention, 21(5), 1333–1338.
Siegman-Igra, Y., Ravona, R., Primerman, H., & Giladi, M. (1998). Pseudomonas aeruginosa bacteremia: An analysis of 123 episodes, with particular emphasis on the effect of antibiotic therapy. International Journal of Infectious Diseases, 2(4), 211–215. https://doi.org/10.1016/s1201-9712(98)90055-8
Maschmeyer, G., & Braveny, I. (2000). Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s. European Journal of Clinical Microbiology and Infectious Diseases, 19(12), 915–925.
Rodriguez, R. M., Hernandez, B. Y., Menor, M., Deng, Y., & Khadka, V. S. (2020). The landscape of bacterial presence in tumor and adjacent normal tissue across 9 major cancer types using TCGA exome sequencing. Computational and Structural Biotechnology Journal, 18, 631–641.
Gnanasekar, A., Castaneda, G., Iyangar, A., Magesh, S., Perez, D., Chakladar, J., Li, W. T., Bouvet, M., Chang, E. Y., & Ongkeko, W. M. (2021). The intratumor microbiome predicts prognosis across gender and subtypes in papillary thyroid carcinoma. Computational and Structural Biotechnology Journal, 19, 1986–1997.
Zhang, C., Liu, Y., Gao, W., Pan, Y., Gao, Y., Shen, J., & Xiong, H. (2018). The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia. Cancer Medicine, 7(5), 2172–2179.
Haghi, F., Goli, E., Mirzaei, B., & Zeighami, H. (2019). The association between fecal enterotoxigenic B. fragilis with colorectal cancer. BMC Cancer, 19(1), 879.
Cheng, W. T., Kantilal, H. K., & Davamani, F. (2020). The mechanism of Bacteroides fragilis toxin contributes to colon cancer formation. Malaysian Journal of Medical Science, 27(4), 9–21.
Anson, L. W., Chau, K., Sanderson, N., Hoosdally, S., Bradley, P., Iqbal, Z., Phan, H., Foster, D., Oakley, S., Morgan, M., Peto, T. E. A., Modernizing Medical Microbiology Informatics Group M, Crook, D. W., & Pankhurst, L. J. (2018). DNA extraction from primary liquid blood cultures for bloodstream infection diagnosis using whole genome sequencing. Journal of Medical Microbiology, 67(3), 347–57.
Forde, B. M., Bergh, H., Cuddihy, T., Hajkowicz, K., Hurst, T., Playford, E. G., Henderson, B. C., Runnegar, N., Clark, J., Jennison, A. V., Moss, S., Hume, A., Leroux, H., Beatson, S. A., Paterson, D. L., & Harris, P. N. (2022). Clinical implementation of routine whole-genome sequencing for hospital infection control of multi-drug resistant pathogens. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac726
Acknowledgements
Authors thank USF research computing and Ms. Corinne Walters for managing the extensive admin support for obtaining approvals for database access.
Author information
Authors and Affiliations
Contributions
JUQ: conceptualization; formal analysis; methodology; software; visualization; writing—review and editing. MJD: methodology; software. TIH: resources; methodology; software. JCK: resources; methodology; software. SZ: methodology; software. JED: methodology; software. KJC: methodology; software. GB: project administration; resources; supervision; writing—review and editing.
Corresponding author
Ethics declarations
Conflict of interest
Authors have nothing to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Quach, J.U., Diaz, M.J., Huda, T.I. et al. Bacterial Sequencing Reads in Blood Exome Files from Melanoma and Cervical Cancer Patients are Associated with Cancer Recurrence. Mol Biotechnol 65, 1476–1484 (2023). https://doi.org/10.1007/s12033-023-00663-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12033-023-00663-9